If you need more lookups,
subscriptions start at $34 USD/month.
Rose L. Location
California, United States
Rose L. Work
2026 -now Senior Vice President Clinical Development @
2023 -2026 Vice President Clinical Development @ AnHeart Therapeutics/Nuvation Bio
2020 -2023 Vice President of Clinical Development @
2011 -2022 Associate Clinical Professor of Neurology @
2019 -2020 Executive Medical Director @
2016 -2019 Senior Medical Director @
2011 -2016 Medical Director, Oncology Development @
2011 -2014 Director of Translational Neuro-oncology @ Norris Comprehensive Cancer Center
2010 -2011 Assistant Professor of Epidemiology @
2005 -2011 Assistant Professor of Neurology @
2000 -2002 Neuro-oncology fellow; Chief fellow (2001 - 2002) @ Memorial Sloan Kettering Cancer Center
1997 -2000 Resident in Neurology @ Columbia University Neurological Institute
Rose L. Education
McMaster University
Master of Science - MS (Health Research Methodology)
2003-2005
Western University
MD (Medicine)
1992-1996
MIT Sloan School of Management
Certificate Artificial Intelligence in Biotech and Pharma
2026
Rose L. Skills
Neurology
Molecular Genetics
Clinical Research
Biotechnology
Cancer Research
Epidemiology
Oncology
translational research
neuro-oncology
Genetics
Clinical Trials
population sciences
Clinical development
Drug safety
Medicine
Neuroscience
Cancer
Science
Neuro Oncology
Rose L. Summary
Rose L., based in California, United States, is currently a Senior Vice President Clinical Development at Elevar Therapeutics. Rose L. brings experience from previous roles at AnHeart Therapeutics/Nuvation Bio, Adicet Bio, Inc, The University of Southern California and Iovance Biotherapeutics, Inc.. Rose L. holds a 2003 - 2005 Master of Science - MS in Health Research Methodology @ McMaster University. With a robust skill set that includes Neurology, Molecular Genetics, Clinical Research, Biotechnology, Cancer Research and more. Rose L. has 1 emails and 2 mobile phone numbers on RocketReach.
Looking for a different Rose L.?
Find contact details for 700 million professionals.